Why Insulet Corporation (PODD) stock fell 6.9% intraday on Friday, November 6, 2026
Insulet Corporation (PODD) traded at $145.32 as of 10:31 AM ET, down 6.92% on Friday, November 6, 2026, on volume of 276,032 shares (0.2× its 3-month average); market value about $10.10B.
PODD was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.
What happened: primary sources
Events Nexqual found for PODD on Friday, November 6, 2026 or the trading day before (November 5, 2026):
- Nov 6, 2026: UBS: Target raised, Neutral, price target $150 → $171
- Nov 5, 2026: JP Morgan: Target raised, Neutral, price target $152 → $170
- Nov 5, 2026: Citigroup: Target raised, Neutral, price target $150 → $170
- Nov 5, 2026: Leerink Partners: Target raised, Market Perform, price target $143 → $167
- Nov 5, 2026: RBC Capital: Target raised, Outperform, price target $160 → $180
- Nov 5, 2026: Bernstein: Target raised, Outperform, price target $175 → $200
- Nov 6, 2026: One of 5 Medical Devices stocks among the day's biggest losers (IRTC, AORT, GMED, PODD, TNDM), with no comparable group among the biggest gainers
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on PODD
PODD stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 6, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:31 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:31 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt